The Biotech Growth Trust
The Company seeks capital appreciation through investment in the worldwide biotechnology industry.
Why invest in the Biotech Growth Trust?
In order to achieve its investment objective
The Biotech Growth Trust invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis.
Latest insight
The Biotech Growth Trust (BIOG) - Podcast Interview, May 2026
Listen to BIOG's Portfolio Manager, Geoffrey Hsu, provide an overview of the trust's strategy and how they are positioned for the next pahse of growth in his latest interview on the John Baron Portfolios Podcast.
During the interview, Geoff explains how the trust navigates the world of biotech investing, outlining OrbiMed's rigorous bottom-up process that combines deep scientific, clinical and financial analysis to identify companies develping innovatinve new medicines.
The conversation explores recent performance or emerging biotech, why valuations continue to look compelling, and how improving funding conditions, M&A activity and a rich pipeline of clinical catalayst could drive a recovery.
Share price
View share price detail
Factsheets
How to invest
The Company’s shares are traded openly on the London Stock Exchange and can be purchased through a stock broker or other financial intermediary.
£279.5m
Our Net Asset Value*
Source: Frostrow Capital LLP
*As at 30 April 2026
Register for email alerts
Read the latest Regulatory News Service (RNS) announcements from The Biotech Growth Trust.
Sign up to The Biotech Growth Trust mailing list for our monthly factsheet.
Investor Disclosure Document